Abdominal Imaging - Original Article

Performance of apparent diffusion coefficient values and ratios for the prediction of prostate cancer aggressiveness across different MRI acquisition settings

• Ercan Karaarslan
• Aylin Altan Kus
• Deniz Alis
• Umut Can Karaarslan
• Yesim Saglican
• Omer Burak Argun
• Ali Riza Kural

The value of dynamic contrast-enhanced MRI in the detection of recurrent prostate cancer after external beam radiotherapy: correlation with transrectal ultrasound and pathological findings

• Taylan Kara
• Deniz Akata
• Fadıl Akyol
• Muşturay Karçaaltıncaba
• Mustafa Özmen

Diffusion-weighted MRI of urinary bladder and prostate cancers

• Özgür Kılıçkesmez
• Tan Cimilli
• Ercan İnci
• Arda Kayhan
• Sibel Bayramoğlu
• Neslihan Taşdelen
• Nevzat Gürmen

Arterial input function for quantitative dynamic contrast-enhanced MRI to diagnose prostate cancer

• Farid Ziayee
• Anja Mueller-Lutz
• Janina Gross
• Tim Ullrich
• Michael Quentin
• Christian Arsov
• Gerald Antoch
• Hans-Jörg Wittsack
• Lars Schimmöller

The value of diffusion-weighted MRI for prostate cancer detection and localization

• Ahmet Baki Yağcı
• Nurgül Özarı
• Zafer Aybek
• Ender Düzcan

Prostate cancer detection with MRI: is dynamic contrast-enhanced imaging necessary in addition to diffusion-weighted imaging?

• Jin Iwazawa
• Takashi Mitani
• Seitaro Sassa
• Shoichi Ohue

Natural history of small index lesions suspicious for prostate cancer on multiparametric MRI: recommendations for interval imaging follow-up

• Soroush Rais-Bahrami
• Barış Türkbey
• Ardeshir R. Rastinehad
• Annerleim Walton-Diaz
• Anthony N. Hoang
• M. Minhaj Siddiqui
• Lambros Stamatakis
• Hong Truong
• Jeffrey W. Nix
• Srinivas Vourganti
• Kinzya B. Grant
• Maria J. Merino
• Bradford J. Wood
• Peter L. Choyke
• Peter A. Pinto

Can the Gleason score be predicted in patients with prostate cancer? A dynamic contrast-enhanced MRI, ⁽⁶⁸⁾Ga-PSMA PET/CT, PSA, and PSA-density comparison study

• Hüseyin Akkaya
• Okan Dilek
• Selim Özdemir
• Zeynel Abidin Taş
• İhsan Sabri Öztürk
• Bozkurt Gülek

Prostate zones and tumor morphological parameters on magnetic resonance imaging for predicting the tumor-stage diagnosis of prostate cancer

• Shanshan Xu
• Xiaobing Liu
• Xiaoqin Zhang
• Huihui Ji
• Runyuan Wang
• Huilin Cui
• Jinfeng Ma
• Yongjian Nian
• Yi Wu
• Ximei Cao

Abdominal Imaging - Review

MRI of localized prostate cancer: coming of age in the PSA era

• Barış Türkbey
• Marcelino Bernardo
• Maria J. Merino
• Bradford J. Wood
• Peter A. Pinto
• Peter L. Choyke

Artificial intelligence at the intersection of pathology and radiology in prostate cancer

• Stephanie A. Harmon
• Sena Tuncer
• Thomas Sanford
• Peter L. Choyke
• Barış Türkbey

Local staging of prostate cancer with MRI

• Fatma Nur Soylu
• Scott Eggener
• Aytekin Oto
• Fatma Nur Soylu
• Scott Eggener
• Aytekin Oto

Modality-Based (US, CT, MRI, PET-CT) Imaging - Original Article

Multiparametric MRI for the detection of local recurrence of prostate cancer in the setting of biochemical recurrence after low dose rate brachytherapy

• Luca F. Valle
• Matthew D. Greer
• Joanna H. Shih
• Tristan Barrett
• Yan Mee Law
• Andrew B. Rosenkrantz
• Haytham Shebel
• Akhil Muthigi
• Daniel Su
• Maria J. Merino
• Bradford J. Wood
• Peter A. Pinto
• Andra V. Krauze
• Aradhana Kaushal
• Peter L. Choyke
• Barış Türkbey
• Deborah E. Citrin

Interventional Radiology - Technical Note

MRI-TRUS fusion for electrode positioning during irreversible electroporation for treatment of prostate cancer

• Alexander D. J. Baur
• Federico Collettini
• Judith Enders
• Andreas Maxeiner
• Vera Schreiter
• Carsten Stephan
• Bernhard Gebauer
• Bernd Hamm
• Thomas Fischer

Interventional Radiology - Original Article

Irreversible electroporation for the treatment of localized prostate cancer: a summary of imaging findings and treatment feedback

• Matthijs J. Scheltema
• Arnoud W. Postema
• Daniel M. de Bruin
• Mara Buijs
• Marc R. Engelbrecht
• M. Pilar Laguna
• Hessel Wijkstra
• Theo M. de Reijke
• Jean J.M.C.H. de la Rosette

MRI-guided focal laser ablation of prostate cancer: a prospective single-arm, single-center trial with 3 years of follow-up

• Sherif Mehralivand
• Arvin K. George
• Anthony N. Hoang
• Soroush Rais-Bahrami
• Ardeshir R. Rastinehad
• Amir H. Lebastchi
• Michael Ahdoot
• Mohummad Minhaj Siddiqui
• Jonathan Bloom
• Abhinav Sidana
• Maria J. Merino
• Peter L. Choyke
• Joanna H. Shih
• Baris Turkbey
• Bradford J. Wood
• Peter A. Pinto